Boston Scientific Corporation (BSX) Fundamentals

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
SHARE INFORMATION
Market Cap$ 61,029,718,163
Shares Outstanding1,431,614,313
Float1,427,395,043
Percent Float99.71%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 11,888,000,000
Latest Fiscal EPS$ 0.69
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1,908
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months98,813,869
Institutional Holdings Percent169.4%
Institutional Sold Previous 3 Months147,192,780
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months53,454
Insider Holdings Percent0.8
Insider Sold Previous 3 Months31,330
Insider Shares Owned11,995,889
TRADING INFO
52 Week High$ 47.50
52 Week Low$ 34.98
52 Week High Change$ -3.31
21 Day Moving Average$ 40.8824
21 Day Extended Moving Average$ 40.9894
50 Day Moving Average$ 38.7484
50 Day Extended Moving Average$ 40.0523
200 Day Moving Average$ 41.4577
200 Day Extended Moving Average$ 40.9923
10 Day Average Volume5,034,704
20 Day Average Volume6,632,545
30 Day Average Volume6,868,214
50 Day Average Volume7,736,704
Alpha0.001121
Beta0.8505
Standard Deviation0.067842
R20.393176
7 Day Price Change$ 0.87
7 Day Percent Change2.08%
21 Day Price Change$ 1.47
21 Day Percent Change3.57%
30 Day Price Change$ 5.46
30 Day Percent Change14.69%
Month to Date Price Change$ 1.58
Month to Date Percent Change3.85%
Quarter to Date Price Change$ 5.36
Quarter to Date Percent Change14.38%
180 Day Price Change$ 0.08
180 Day Percent Change0.19%
200 Day Price Change$ -0.11
200 Day Percent Change-0.26%
Year to Date Price Change$ 0.15
Year to Date Percent Change0.35%

Boston Scientific Corporation (BSX) Key Ratios

PROFITABILITY
EBIT Margin13.1%
EBITDA Margin22.2%
Pre-Tax Profit Margin9.3%
Profit Margin Count7.18%
Gross Margin68.5%
Profit Margin TOT7.18%
INCOME STATEMENTS
Revenue$ 12,329,000,000
Revenue Per Share$ 8.612
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-30.70
Total Debt To Equity0.50
Int Coverage3.10
Current Ratio1.30
Leverage Ratio1.90
Quick Ratio0.60
Long Term Debt To Capital0.35
VALUATION MEASURES
PE Ratio73.20
Enterprise Value$ 69,794,395,300
Price to Sales4.9501
Price to Free Cash-24.60
PE High Last 5 Years493.00
Price To Book3.50
Price To Cash Flow51.20
PE Low Last 5 Years-432.30
Price to Tangible Book-30.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover7.30
Invoice Turnover2.40
Assets Turnover0.40
Return Assets2.77
Return on Equity5.28
Return on Capital4.75

Boston Scientific Corporation (BSX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorErnst & Young LLP
CEOMichael F. Mahoney
Emplyoees41000
Last AuditUQ
CIK0000885725
IndustryMedical Devices & Instruments
SectorHealthcare
NAICSSurgical and Medical Instrument Manufacturing(339112)
CONTACT INFO
Address300 Boston Scientific Way
Marlborough, MA 01752-1234
Websitehttps://www.bostonscientific.com
Facsimile+1 508 650-8923
Telephone+1 508 683-4000
EmailBSXInvestorRelations@bsci.com


Your Recent History
NYSE
BSX
Boston Sci..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.